HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context.

Abstract
Adenoviral vectors are widely used in cancer gene therapy. After systemic administration however, the majority of the virus homes to the liver and the expressed transgene may cause hepatotoxicity. To restrict transgene expression to tumor cells, tumor- or tissue-specific promoters are utilized. The tumor antigen epithelial glycoprotein-2 (EGP-2), also known as Ep-CAM, is expressed in many cancers from different epithelial origins. In this study, the EGP-2 promoter was shown to restrict the expression of luciferase and thymidine kinase in an adenoviral context in different cell lines. In vivo, the EGP-2 promoter mediated efficient expression of luciferase in tumors but showed a 3-log lower activity in liver tissue when compared with the cytomegalovirus (CMV) promoter. Similarly, the EGP-2 promoter mediated specific cell killing after ganciclovir treatment in EGP-2-positive cells. Moreover, in vivo, this treatment regiment did not cause any rise in the liver enzymes aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT), demonstrating absence of liver toxicity. In contrast, CMV-mediated expression of thymidine kinase in combination with ganciclovir treatment resulted in high ASAT and ALAT values. This study demonstrates the value of the EGP-2 promoter to restrict transgene expression to a broad range of tumor types, thereby preventing liver toxicity.
AuthorsW M Gommans, S J van Eert, P M J McLaughlin, M C Harmsen, M Yamamoto, D T Curiel, H J Haisma, M G Rots
JournalCancer gene therapy (Cancer Gene Ther) Vol. 13 Issue 2 Pg. 150-8 (Feb 2006) ISSN: 0929-1903 [Print] England
PMID16096650 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antigens, Neoplasm
  • Cell Adhesion Molecules
  • DNA Primers
  • EPCAM protein, human
  • Epithelial Cell Adhesion Molecule
  • Luciferases
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Thymidine Kinase
  • Ganciclovir
Topics
  • Adenoviridae
  • Alanine Transaminase (metabolism)
  • Animals
  • Antigens, Neoplasm (genetics)
  • Aspartate Aminotransferases (metabolism)
  • Cell Adhesion Molecules (genetics)
  • Cell Line, Tumor
  • DNA Primers
  • Epithelial Cell Adhesion Molecule
  • Ganciclovir (toxicity)
  • Gene Expression Regulation, Neoplastic
  • Genetic Therapy (methods)
  • Genetic Vectors (genetics)
  • Humans
  • Luciferases (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms (therapy)
  • Promoter Regions, Genetic (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thymidine Kinase (metabolism, toxicity)
  • Toxicity Tests
  • Transgenes (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: